Skip to content

Q/C TECHNOLOGIES, INC.

QCLS · XNAS

CIK 1321834fmd_1RV8PED7Z3X4TEZMY1T54HKCTQManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2013 to Jun 30, 2026, 54 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading